Quick Answer
UTAH MEDICAL PRODUCTS INC reported R&D Expense of $668.0 thousand for fiscal year 2025.
UTAH MEDICAL PRODUCTS INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $668.0K | -17.8% |
| 2024 | $813.0K | +45.2% |
| 2023 | $560.0K | +13.6% |
| 2022 | $493.0K | -6.3% |
| 2021 | $526.0K | +8.2% |
| 2020 | $486.0K | +0.6% |
| 2019 | $483.0K | +6.4% |
| 2018 | $454.0K | +1.6% |
| 2017 | $447.0K | -5.9% |
| 2016 | $475.0K | -9.0% |
| 2015 | $522.0K | +13.5% |
| 2014 | $460.0K | -6.3% |
| 2013 | $491.0K | -12.8% |
| 2012 | $563.0K | +208.7% |
| 2011 | -$518.0K | -230.5% |
| 2010 | $397.0K | +10.0% |
| 2009 | $361.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $167.0K | -2.9% | +23.7% |
| June 30, 2025 | $135.0K | -47.1% | -12.3% |
| March 31, 2025 | $154.0K | -42.1% | -10.5% |
| September 30, 2024 | $172.0K | +24.6% | -32.5% |
| June 30, 2024 | $255.0K | +91.7% | -4.1% |
| March 31, 2024 | $266.0K | +84.7% | +92.8% |
| September 30, 2023 | $138.0K | +23.2% | +3.8% |
| June 30, 2023 | $133.0K | -1.5% | -7.6% |
- UTAH MEDICAL PRODUCTS INC showed a decrease of -17.8% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, UTAH MEDICAL PRODUCTS INC’s r&d expense has grown by 85.0% (from $361.0 thousand to $668.0 thousand).
- The most recent figure is from UTAH MEDICAL PRODUCTS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: